CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
94.48
+1.70 (1.83%)
At close: Oct 22, 2026, 4:00 PM EDT
94.69
+0.21 (0.22%)
After-hours: Oct 22, 2026, 5:06 PM EDT
CVS Health Stock Forecast
Stock Price Forecast
According to 27 analysts polled by S&P Global, CVS Health stock has a consensus rating of "Strong Buy" and an average price target of $115.48. The average 1-year stock price forecast is 22.23% higher than the current stock price, while the lowest is $103 (+9.02%) and the highest is $145 (+53.47%).
Price Target: $115.48 (+22.23%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CVS Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 18 | 18 | 18 | 18 | 18 | 18 |
| Buy | 6 | 6 | 6 | 6 | 7 | 7 |
| Hold | 4 | 4 | 4 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 28 | 28 | 28 | 27 | 27 | 27 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $110 | Buy | Maintains | $110 | +16.43% | Oct 13, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $119 → $112 | Buy | Reiterates | $119 → $112 | +18.54% | Oct 12, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $110 | Buy | Maintains | $110 | +16.43% | Oct 9, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $113 | Buy | Maintains | $113 | +19.60% | Oct 7, 2026 |
| Bernstein | Bernstein | Buy Maintains $106 → $112 | Buy | Maintains | $106 → $112 | +18.54% | Oct 5, 2026 |
Financial Forecast
Revenue This Year
418.04B
from 399.83B
Increased by 4.55%
Revenue Next Year
430.06B
from 418.04B
Increased by 2.87%
EPS This Year
8.04
from 6.75
Increased by 19.15%
EPS Next Year
8.53
from 8.04
Increased by 6.11%
EPS and Forward PE are based on non-GAAP adjusted numbers.